DCT Industrial Trust Inc. (NYSE: DCT) Investor Investigation Over Possible Wrongdoing In Acquisition Announced

Investors who purchased shares of DCT Industrial Trust Inc. (NYSE: DCT) and currently hold any of those NYSE: DCT shares have certain options and should contact the Shareholders Foundation, Inc.

To have your information reviewed for options and to recieve notifications about this investigation, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.
Company Name(s): 
DCT Industrial Trust
Affected Securities: 
NYSE: DCT

An investigation on behalf of investors, who currently hold shares of DCT Industrial Trust Inc. (NYSE: DCT), was announced concerning whether the takeover of DCT Industrial Trust Inc. by Prologis, Inc is unfair to NYSE: DCT stockholders.

The investigation by a law firm concerns whether certain officers and directors of DCT Industrial Trust Inc. breached their fiduciary duties owed to NYSE: DCT investors in connection with the proposed acquisition.

On April 29, 2018, Prologis, Inc. (NYSE: PLD) and DCT Industrial Trust Inc. (NYSE: DCT) announced that the two companies have entered into a merger agreement by which Prologis will acquire DCT Industrial Trust Inc. (NYSE: DCT) for $8.4 billion in a stock-for-stock transaction, including the assumption of debt. Under the terms of the agreement, DCT Industrial Trust Inc. (NYSE: DCT) shareholders will receive 1.02 Prologis shares for each DCT Industrial Trust Inc. (NYSE: DCT) share they own. Based on a closing price of $66.58 for NYSE:PLD shares on April 27, 2018, investors in DCT Industrial Trust Inc. (NYSE: DCT) will receive a value of approximately $67.91 per NYSE: DCT share.

However, given that at least one analyst has set the high target price for NYSE: DCT shares at $69.00 per share, the investigation concerns whether the offer is unfair to DCT Industrial Trust Inc. (NYSE: DCT stockholders. More specifically, the investigation concerns whether the DCT Industrial Trust Inc. (NYSE: DCT Board of Directors undertook an adequate sales process, adequately shopped the company before entering into the transaction, maximized shareholder value by negotiating the best price, and acted in the shareholders' best interests in connection with the proposed sale.